// App-Quantinova.ai

498.0 : Gemcitabine plus nab-paclitaxel use in metastatic pancreatic cancer: A study of 40 patients.

Researchers

Presenter

  • Ivan Barrera

Principal Investigators

  • Sabin Dragos Filimon

  • Jassy Meng

  • Tomas Kavan

  • Young soo Rho

  • Gerald Batist

  • Petr Kavan

Medical Centers

  • Segal Cancer Center/Jewish General Hospital, McGill University, Montreal, QC, Canada

  • Department of Oncology, Faculty of Medicine, McGill University, Montreal, QC, Canada

  • Department of Oncology, Faculty of Medicine, McGill University and Segal Cancer Centre - Jewish General Hospital, McGill University, Montreal, QC, Canada

  • Montreal University, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Gemcitabine

  • Paclitaxel

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved